Entity DossierOrganization

NOVARTIS

DC · US

pharmaceuticals

Tracked direct giving

Tracked donations to candidate

LDA reported lobbying spend

$8,850,000

Connections

The Money Trail

Money connected to NOVARTIS

These trails are from entities directly connected to NOVARTIS through ownership, employment, or organizational ties.

$11K

3 transactions across 2 counterparties

Brownstein Hyatt Farber Schreck directed $10K to WITH HONOR PAC across 2 contributions. Brownstein Hyatt Farber Schreck advocates for Overdraft Lending: Very Large Financial Institutions.

Nov 2023individual→ Overdraft Lending: Very Large Financial Institutio… no recorded vote

BGR GOVERNMENT AFFAIRS directed $1K to GUTHRIE FOR CONGRESS.

Oct 2024individual

$11K tracked across 2 counterparties·2 policy outcomes

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues

$17.5M

MMMMedicare/Medicaid

$15.9M

TRDTrade

$14.3M

BUDBudget/Appropriations

$14.0M

TAXTaxation/Internal Revenue Code

$14.0M

CPTCopyright/Patent/Trademark

$13.5M

LBRLabor/Employment

$13.3M

SCIScience

$1.8M

PHAPharmacy

$40K

MEDMedical/Disease Research

$40K

Lobbying Firms Retained

NOVARTIS$13.3M

BROWNSTEIN HYATT FARBER SCHRECK, LLP$960K

TIBER CREEK HEALTH STRATEGIES, INC.$840K

BGR GOVERNMENT AFFAIRS$840K

TARPLIN, DOWNS & YOUNG, LLC$780K

MONUMENT ADVOCACY$480K

DLA PIPER LLP (US)$280K

Corcoran & Associates, Inc. dba Corcoran Partners$270K

RESOLUTION PUBLIC AFFAIRS, LLC$270K

EAST END GROUP, LLC$90K

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph

0 nodes · 0 edgesHover for labels · Double-click to expand

Loading graph...

Person

Organization

PAC

Gov Body

Legislature

Think Tank

Industry

Outcome

Click a node to see details

Double-click to expand its connections

Relationships

Type	Connected To	Details	Source
Employed by	TIBER CREEK HEALTH STRATEGIES, INC.	Hired TIBER CREEK HEALTH STRATEGIES, INC. to lobby on PBM Reform Act	Source
Employed by	BGR GOVERNMENT AFFAIRS	Hired BGR GOVERNMENT AFFAIRS to lobby on PBM Reform Act	Source
Lobbied for	Pharmacy Benefit Manager Reform Act	LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $20,000	Source
Employed by	Brownstein Hyatt Farber Schreck	Hired BROWNSTEIN HYATT FARBER SCHRECK, LLP to lobby on PBM Reform Act	Source
Lobbied for	MARCH-IN Rights Proposal (NIH Framework)	LDA filing: lobbied on NIH March-In Rights, period 3rd Quarter (July 1 - Sep 30), reported amount $1,360,000	Source
Employed by	TARPLIN, DOWNS & YOUNG, LLC	Hired TARPLIN, DOWNS & YOUNG, LLC to lobby on Pharmaceuticals	Source
Employed by	Corcoran & Associates, Inc. dba Corcoran Partners	Hired CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS to lobby on Pharmaceuticals	Source
commented_on	Centers for Medicare & Medicaid Services	Public comment on CMS-2024-0157: Medicare Program: Alternative Payment Model Updates and the Increasing Organ Transplant Access Model	Source
Employed by	BROWNSTEIN HYATT FARBER SCHRECK, LLP	Hired BROWNSTEIN HYATT FARBER SCHRECK, LLP to lobby on PBM Reform Act	Source
Employed by	EAST END GROUP, LLC	Hired EAST END GROUP, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)	Source
Employed by	MONUMENT ADVOCACY	Hired MONUMENT ADVOCACY to lobby (1st Quarter (Jan 1 - Mar 31) 2023)	Source
Employed by	RESOLUTION PUBLIC AFFAIRS, LLC	Hired RESOLUTION PUBLIC AFFAIRS, LLC to lobby (3rd Quarter (July 1 - Sep 30) 2023)	Source
Employed by	DLA PIPER LLP (US)	Hired DLA PIPER LLP (US) to lobby (2nd Quarter (Apr 1 - June 30) 2025)	Source